×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateur : Pr Eric Lambaudie

Au programme de cette soirée

18:30 Introduction
 
18:35 La caractérisation radiologique (ORADS)
Dr Estelle Pipon
 
18:55 Les scores chirurgicaux
Dr Guillaume Blache
 
19:15 Le KELIM
Pr Benoit You
 
19:35 Quel score en anatomopathologie ?
Pr Mojgan Devouassoux
 
19:55 Débat/Discussion et réponses aux questions
 

 

Shooting date : 2023-09-25
Last update : 2023-10-18
1 comment
Join the Discussion
  • Abdelmadjid S. Merci beaucoup pour vous tous

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
    Honolulu : Wednesday, January 22nd 2025 from 06am to 07am (GMT+1)
    San Francisco : Wednesday, January 22nd 2025 from 08am to 09am (GMT+1)
    New York : Wednesday, January 22nd 2025 from 11am to 12pm (GMT+1)
    Buenos Aires : Wednesday, January 22nd 2025 from 01pm to 02pm (GMT+1)
    London / Dublin : Wednesday, January 22nd 2025 from 04pm to 05pm (GMT+1)
    Paris / Berlin : Wednesday, January 22nd 2025 from 05pm to 06pm (GMT+1)
    Istanbul : Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
    Moscou / Dubaï : Wednesday, January 22nd 2025 from 08pm to 09pm (GMT+1)
    Bangkok : Wednesday, January 22nd 2025 from 11pm to 12am (GMT+1)
    Shanghai : Thursday, January 23rd 2025 from 12am to 01am (GMT+1)
    Tokyo : Thursday, January 23rd 2025 from 01am to 02am (GMT+1)
    Sydney : Thursday, January 23rd 2025 from 02am to 03am (GMT+1)
    Wellington : Thursday, January 23rd 2025 from 04am to 05am (GMT+1)

    Prise en charge des cancers de l'ovaire en rechute :

    état des lieux et perspectives

    Share
    Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, December 13th 2022 from 06am to 07:30am (GMT+1)
    San Francisco : Tuesday, December 13th 2022 from 08am to 09:30am (GMT+1)
    New York : Tuesday, December 13th 2022 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Tuesday, December 13th 2022 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Tuesday, December 13th 2022 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Tuesday, December 13th 2022 from 05pm to 06:30pm (GMT+1)
    Istanbul : Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, December 13th 2022 from 08pm to 09:30pm (GMT+1)
    Bangkok : Tuesday, December 13th 2022 from 11pm to 12:30am (GMT+1)
    Shanghai : Wednesday, December 14th 2022 from 12am to 01:30am (GMT+1)
    Tokyo : Wednesday, December 14th 2022 from 01am to 02:30am (GMT+1)
    Sydney : Wednesday, December 14th 2022 from 02am to 03:30am (GMT+1)
    Wellington : Wednesday, December 14th 2022 from 04am to 05:30am (GMT+1)

    Last improvements in advanced ovarian cancer treatment

    Trials that have or will impact practices in the management of patients with advanced ovarian cancer

    Share
    Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
    Honolulu : Tuesday, September 5th 2023 from 06:30am to 08am (GMT+2)
    San Francisco : Tuesday, September 5th 2023 from 09:30am to 11am (GMT+2)
    New York : Tuesday, September 5th 2023 from 12:30pm to 02pm (GMT+2)
    Buenos Aires : Tuesday, September 5th 2023 from 01:30pm to 03pm (GMT+2)
    Reykjavik : Tuesday, September 5th 2023 from 04:30pm to 06pm (GMT+2)
    London / Dublin : Tuesday, September 5th 2023 from 05:30pm to 07pm (GMT+2)
    Paris / Berlin : Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
    Istanbul : Tuesday, September 5th 2023 from 07:30pm to 09pm (GMT+2)
    Moscou / Dubaï : Tuesday, September 5th 2023 from 08:30pm to 10pm (GMT+2)
    Bangkok : Tuesday, September 5th 2023 from 11:30pm to 01am (GMT+2)
    Shanghai : Wednesday, September 6th 2023 from 12:30am to 02am (GMT+2)
    Tokyo : Wednesday, September 6th 2023 from 01:30am to 03am (GMT+2)
    Sydney : Wednesday, September 6th 2023 from 03:30am to 05am (GMT+2)
    Wellington : Wednesday, September 6th 2023 from 05:30am to 07am (GMT+2)

    Les nouveaux enjeux de la prise en charge du cancer de l’ovaire en première ligne : L’exemple d...

    Cycle d'enseignement sur le cancer de l'ovaire - Première session

    Share
    Tuesday, October 10th 2023 from 06:30pm to 08pm (GMT+2)
    Honolulu : Tuesday, October 10th 2023 from 06:30am to 08am (GMT+2)
    San Francisco : Tuesday, October 10th 2023 from 09:30am to 11am (GMT+2)
    New York : Tuesday, October 10th 2023 from 12:30pm to 02pm (GMT+2)
    Buenos Aires : Tuesday, October 10th 2023 from 01:30pm to 03pm (GMT+2)
    Reykjavik : Tuesday, October 10th 2023 from 04:30pm to 06pm (GMT+2)
    London / Dublin : Tuesday, October 10th 2023 from 05:30pm to 07pm (GMT+2)
    Paris / Berlin : Tuesday, October 10th 2023 from 06:30pm to 08pm (GMT+2)
    Istanbul : Tuesday, October 10th 2023 from 07:30pm to 09pm (GMT+2)
    Moscou / Dubaï : Tuesday, October 10th 2023 from 08:30pm to 10pm (GMT+2)
    Bangkok : Tuesday, October 10th 2023 from 11:30pm to 01am (GMT+2)
    Shanghai : Wednesday, October 11th 2023 from 12:30am to 02am (GMT+2)
    Tokyo : Wednesday, October 11th 2023 from 01:30am to 03am (GMT+2)
    Sydney : Wednesday, October 11th 2023 from 03:30am to 05am (GMT+2)
    Wellington : Wednesday, October 11th 2023 from 05:30am to 07am (GMT+2)

    La prise en charge du cancer de l’ovaire chez la personne âgée : expériences croisées du CGFL ...

    Cycle d'enseignement sur le cancer de l'ovaire - Deuxième session

    Share
    Scroll Up